The initial public offering window continues to draw a steady stream of investment from venture and private equity investors allocating funding to what’s referred to as the crossover round that precedes an IPO. That was one of the takeaways of the MoneyTree report analyzing third quarter investment trends by the National Venture Capital Association and PricewaterhouseCoopers. Although it was always going to be tough to duplicate what was a blockbuster second quarter, Greg Vlahos, a partner with PwC, said in a phone interview with MedCity News that he was encouraged by biotechnology and medical device investment trends.
Hey, check out all the engineering jobs. Post your resume today!
